Format

Send to

Choose Destination
J Allergy Clin Immunol. 2014 Oct;134(4):769-79. doi: 10.1016/j.jaci.2014.08.008.

Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches.

Author information

1
Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Health, Denver, Colo. Electronic address: leungd@njhealth.org.
2
Department of Dermatology and the Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

Abstract

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. It often precedes the development of food allergy and asthma. Recent insights into AD reveal abnormalities in terminal differentiation of the epidermal epithelium leading to a defective stratum corneum, which allows enhanced allergen penetration and systemic IgE sensitization. Atopic skin is also predisposed to colonization or infection by pathogenic microbes, most notably Staphylococcus aureus and herpes simplex virus. Causes of this abnormal skin barrier are complex and driven by a combination of genetic, environmental, and immunologic factors. These factors likely account for the heterogeneity of AD onset and the severity and natural history of this skin disease. Recent studies suggest prevention of AD can be achieved through early interventions to protect the skin barrier. Onset of lesional AD requires effective control of local and systemic immune activation for optimal management. Early intervention might improve long-term outcomes for AD and reduce the systemic allergen sensitization that leads to associated allergic diseases in the gastrointestinal and respiratory tract.

KEYWORDS:

Atopic dermatitis; eczema; filaggrin; immune; infection; skin epithelium

PMID:
25282559
PMCID:
PMC4186710
DOI:
10.1016/j.jaci.2014.08.008
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center